Haploidentical Hematopoietic Cell Transplantation for metabolic diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 4 Jun 2020: Trial registered, NCT04414046
  2. 22 Jul 2020: Trial started, NCT04414046

The trials

NCT04414046: TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

State
Under way
Phase
Phase 2
People
17 planned
Started
22 Jul 2020
Primary completion
30 Jun 2027
Arms
TCR alpha beta T cell depletion
Results
None posted
  1. 4 Jun 2020: Trial registered
  2. 22 Jul 2020: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.